Full video transcriptClick to expand
Auto-generated transcript of @kaebae56's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Three Best stocks to buy tomorrow, Friday, May 1st as soon as the stock market opens up,
- 0:04regardless if these three stocks are going up or if these two stocks are coming down,
- 0:07here are going to be the three best stocks to buy tomorrow on Friday. And this is coming from
- 0:10somebody that has multiple millions of dollars invested in the stock market at just 25 years old.
- 0:14Coming in at number one is a company that use every single day without realizing and that is
- 0:18MasterCard. MasterCard is seeing its revenue up 16% year over year to over $8.4 billion,
- 0:24all while the company continues to buy back more of its stock, about $5.7 billion worth of share
- 0:29buybacks. Before we jump in at number two, make sure to give me a follow and comment the
- 0:32word stock and I'll send you over my portfolio so that way you can check out and see what I buy
- 0:35and sell in real time. Coming in at number two is a massive semiconductor that does report the
- 0:39earnings on May 5th and they are expected to exceed all earnings guidelines and that is AMD. I'm
- 0:45personally a big buy of AMD especially at the semiconductor since you show no weakness within
- 0:50video. Coming in at number three is a big tech company in which the CEO did just step down and
- 0:55that is Apple. Apple also did just announce that about a one cent increase to their dividend which
- 1:00might not seem like a lot but they had impressive earnings on the top line and the bottom line
- 1:04beats across the board so I'm super bullish on this company especially their very supply could drain.
Peptide therapy claims vs. what the studies actually show
Quick answer
This video was miscategorized under peptide therapy but contains no health, medical, or peptide-related content of any kind. The creator discusses stock picks for MasterCard, AMD, and Apple based on earnings reports and personal investing opinions. There is no clinical context to evaluate because no clinical claims were made.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide therapy claims vs. what the studies actually show, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide therapy claims vs. what the studies actually show is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide therapy claims vs. what the studies actually show" from Connor Finance 🐂. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video was miscategorized under peptide therapy but contains no health, medical, or peptide-related content of any kind.
The reason this review is not generic is the source wording and the canonical claim label "peptides 3 best stocks to buy friday may 1 stockstobuy investingtips." In this clip, the useful excerpt is: "Three Best stocks to buy tomorrow, Friday, May 1st as soon as the stock market opens up, regardless if these three stocks are going up or if these two stocks are coming down, here are going to be the three best stocks to buy tomorrow on..." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
This video was miscategorized under peptide therapy but contains no health, medical, or peptide-related content of any kind.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This video was miscategorized under peptide therapy but contains no health, medical, or peptide-related content of any kind. The creator discusses stock picks for MasterCard, AMD, and Apple based on earnings reports and personal investing opinions. There is no clinical context to evaluate because no clinical claims were made.
- This video was miscategorized as peptide therapy content. It contains zero health or medical information and should not influence any decisions about peptide use or wellness protocols.
- Apple CEO Tim Cook had not stepped down as of May 1, 2025, making that claim a direct factual error in the video.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- This video was miscategorized as peptide therapy content. It contains zero health or medical information and should not influence any decisions about peptide use or wellness protocols.
- Apple CEO Tim Cook had not stepped down as of May 1, 2025, making that claim a direct factual error in the video.
- Mastercard's Q1 2025 revenue growth and buyback activity are broadly consistent with the figures cited, though exact numbers depend on how revenue is defined.
- AMD earnings predictions made before a report date are speculation, not analysis. AMD has historically shown earnings surprises in both directions.
- The SEC has specifically targeted social media stock promoters, including a 2022 enforcement action against creators who touted stocks to large audiences without proper registration.
- Asking viewers to comment a keyword to receive a portfolio link is a social media growth tactic, not a regulated financial advisory service, and carries no fiduciary obligation to the viewer.
- Retail investors who buy stocks immediately after a viral TikTok recommendation often enter after the creator's position is already established, a dynamic that does not favor the late buyer.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kaebae56 actually say?
This video has nothing to do with peptide therapy. @kaebae56 is a stock-picking TikToker who says he has "multiple millions of dollars invested in the stock market at just 25 years old" and is recommending three stocks to buy on May 1st: MasterCard, AMD, and Apple. That's the actual content here, and it landed in a peptide therapy category by mistake or miscategorization.
His reasoning: MasterCard revenue is "up 16% year over year to over $8.4 billion" with $5.7 billion in buybacks. AMD is a "massive semiconductor" expected to "exceed all earnings guidelines" when it reports May 5th. Apple just had a CEO step down, announced a dividend increase, and posted "beats across the board." He closes by directing viewers to comment "stock" so he can share his portfolio, which is a classic social media engagement funnel.
Does the science back this up?
There is no science to evaluate here. This is a stock-picking video, not a health or medical claim. No clinical trials, no peer-reviewed research, and no biomarkers are relevant to what @kaebae56 is saying. The peptide category tag on this video is simply wrong.
What does apply is financial regulation and basic investing literacy. The SEC requires anyone providing personalized investment advice to be a registered investment adviser. Recommending specific stocks to a public audience of 13,000 viewers while promoting your own portfolio is the kind of activity regulators watch closely. A 2022 SEC enforcement sweep targeted social media stock promoters specifically. Whether @kaebae56 crosses that line legally is not our call, but viewers should know the regulatory context exists. The claim about AMD "exceeding all earnings guidelines" before earnings are even reported is not analysis. It is speculation dressed up as confidence.
What did they get wrong (or right)?
The MasterCard revenue figure is in the right ballpark. Mastercard's Q1 2025 earnings did show strong net revenue growth, and buyback activity has been consistent with the figures cited. Credit where it's due: that part checks out directionally.
The AMD claim is where things get shaky. Saying AMD is "expected to exceed all earnings guidelines" before the report is not a fact. It is a prediction, and AMD has had volatile earnings surprises in both directions over recent quarters. Presenting forward earnings expectations as near-certainty is misleading to beginners, which is literally in his hashtags.
The Apple CEO claim is wrong. Tim Cook has not stepped down. As of the time of this video, Cook remains Apple's CEO. It is possible @kaebae56 confused a board-level or divisional leadership change for a CEO departure, but that is a significant factual error about one of the most watched companies on earth.
The "one cent increase to their dividend" framing is technically accurate but strips all context. Apple's dividend yield is under 1%, so the absolute dollar increase is trivial to most retail investors.
What should you actually know?
If you found this video while researching peptide therapy, you are in the wrong place entirely. This creator is talking about equities, not peptides, not recovery protocols, not GHK-Cu or BPC-157. The category tag is a miscategorization and you should seek out content that actually addresses your health questions.
If you are here for the stock content, apply appropriate skepticism. A 25-year-old with millions invested may or may not be telling the truth about their portfolio. The engagement funnel asking you to comment "stock" to receive their portfolio is a common social media growth tactic, not a regulated financial advisory service. Past performance of any portfolio does not predict future results, and buying stocks "as soon as the market opens" based on a TikTok video is a strategy that benefits the person with the bigger position more than the person who follows last. Do your own research, or consult a registered financial adviser.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Connor Finance 🐂 · TikTok creator
13.0K views on this video
3 BEST STOCKS TO BUY FRIDAY : MAY 1 #stockstobuy #investingtips #investingforbeginners #nvidia #stockmarket
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about this video was miscategorized as peptide therapy content. it contains?
This video was miscategorized as peptide therapy content. It contains zero health or medical information and should not influence any decisions about peptide use or wellness protocols.
What does the video say about apple ceo tim cook had not stepped down as of?
Apple CEO Tim Cook had not stepped down as of May 1, 2025, making that claim a direct factual error in the video.
What does the video say about mastercard's q1 2025 revenue growth?
Mastercard's Q1 2025 revenue growth and buyback activity are broadly consistent with the figures cited, though exact numbers depend on how revenue is defined.
What does the video say about amd earnings predictions made before a report date?
AMD earnings predictions made before a report date are speculation, not analysis. AMD has historically shown earnings surprises in both directions.
What does the video say about the sec has specifically targeted social media stock promoters, including?
The SEC has specifically targeted social media stock promoters, including a 2022 enforcement action against creators who touted stocks to large audiences without proper registration.
What does the video say about asking viewers to comment a keyword to receive a portfolio?
Asking viewers to comment a keyword to receive a portfolio link is a social media growth tactic, not a regulated financial advisory service, and carries no fiduciary obligation to the viewer.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Connor Finance 🐂, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.